KRT88P and hypertriglyceridemia: Evaluation of laboratory parameters revealed significantly higher rates of hypertriglyceridemia and hepatitis B core antibody (anti-HBc) positivity in GCLP patients than in LCLP patients (p=0.005 and p=0.016, respectively; Table 4).